Covaxin WHO Approval News: Bharat Biotech Chairman and MD said THIS about WHO Emergency Use Listing - check all details here
On Monday, Bharat Biotech said that the company has submitted all documents required for Emergency Use Listing (EUL) of Covaxin to World Health Organisation (WHO) on July 9, 2021.
Covaxin WHO Approval News: Bharat Biotech said on Monday (July 12) that the company has submitted all documents required for Emergency Use Listing (EUL) of Covaxin to World Health Organisation (WHO) on July 9, 2021. Bharat Biotech said the company now expects that they would receive the EUL for the indigenous COVID-19 vaccine Covaxin at the earliest.
See Zee Business Live TV Streaming Below:
Bharat Biotech also tweeted the statement of Dr. Krishna Ella, Chairman and Managing Director, Bharat Biotech International Limited from its official Twitter handle. Dr. Ella said, "All documents required for Emergency Use Listing (EUL) of COVAXIN have been submitted to WHO as of 9th July. The review process has now commenced with the expectation that we will receive EUL from WHO at the earliest."
COVAXIN® EUL pic.twitter.com/dCilH7KbSk
— BharatBiotech (@BharatBiotech) July 12, 2021
It has to be noted that the nationwide COVID-19 vaccination drive started with Covishield and Covaxin from January 16, 2021. As per an ANI report, a WHO pre-qualification or EUL is necessary for a vaccine company to supply vaccine for global facilities such as Covax or international procurement.
The ANI report states that the WHO has approved the COVID-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio/SII, Johnson and Johnson Janssen, Moderna and Sinopharm for emergency use.
As per the ANI report, Covaxin showed 63.6 per cent efficacy against the Delta variant of COVID-19 which has also spread in other countries as well. The indigenous vaccine Covaxin shows 93.4 per cent efficacy against symptomatic COVID and 63.6 per cent efficacy against asymptomatic COVID-19.
The trial was conducted on 25,800 subjects and the data submitted to the Subject Expert Committee (SEC) showed that the vaccine was 'well-tolerated'.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
08:52 AM IST